METTL14 mediates downregulation of hepatocyte nuclear factor 3γ (HNF3γ) expression levels, promotes cell differentiation to inhibit HCC progression, and is sensitive to sorafenib-induced growth inhibition and apoptosis in HCC cells (Zhou et al., 2020). This evidence concerns the gene METTL14 and hepatocellular carcinoma.